Effect of repeated applications of tenofovir gel on mucosal mediators of immunity and intrinsic antimicrobial activity of cervicovaginal secretions in women at low risk for HIV-1 infection.
Phase of Trial: Phase I
Latest Information Update: 18 Feb 2017
At a glance
- Drugs Tenofovir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 12 May 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 12 May 2010 Actual patient number (30) added as reported by ClinicalTrials.gov.
- 12 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.